Introduction
The Myc-activating chromosomal T(12;15) translocation, the hallmark mutation of BALB/c mouse PCTs, is the direct counterpart of the MYC-activating t(8;14)(q24;q32) in human sporadic Burkitt's lymphoma and, therefore, highly relevant for human cancer.
T(12;15) is of special interest as an experimental model system because it is the only cancer-associated translocation in mice that occurs with high incidence, spontaneity, and cell-type specificity (B lymphocytes) (Potter and Wiener, 1992) . Similar to the human t(8;14) and a number of related oncogene-activating translocations involving immunoglobulin heavy chain (IgH) in human postgerminal center B-cell tumors (reviewed in (Willis and Dyer, 2000; Bergsagel and Kuehl, 2001; Kuppers and Dalla-Favera, 2001 ), T(12;15) is most probably caused by aberrant class switch recombination (CSR).
Highly sensitive PCR methodologies have been developed to detect the reciprocal IgH-Myc breakpoint junction of the T(12;15) exchange (Kovalchuk et al., 2000b) . The ability to identify translocations at the molecular level has shown that T(12;15) is a very early event in mouse plasmacytomagenesis (Janz et al., 1993) . It has further revealed that translocation-bearing cell clones occur also in plasmacytoma (PCT)-resistant mice (Mu¨ller et al., 1996) , for example, as a by-product of normal IgA immune responses (Roschke et al., 1997) . PCR analysis was also instrumental in demonstrating that T(12;15) is a dynamic process that often begins with the exchange between Myc and Cm (the most 5 0 IgH gene) and ends with the juxtaposition of Myc to Ca (the most 3 0 IgH gene) (Kovalchuk et al., 1997) . Comparison of tumor precursor cells and frank tumors indicated that translocation breakpoint regions shorten during PCT development (Mu¨ller et al., 1994) , a notable distinction from human Burkitt's lymphoma . The IgH-Myc junction sequence has also been a useful clonotypic marker in studies on the mobilization and trafficking and the in vivo propagation (Kovalchuk et al., 2002) of translocationbearing cell clones.
DNA sequence analysis of PCR-amplified IgH-Myc breakpoint junctions has firmly linked origin and molecular evolution of T(12;15) with CSR. CSR is a DNA recombination event between IgH switch (S) regions that allows B cells expressing IgM to give rise to progenitors producing IgG, IgA, or IgE (Manis et al., 2002) . Misguided CSR has been implicated in the origin of T(12;15) in three ways. These include the primary IgH-Myc exchange, the approximation of Myc to a critical transcriptional control element, the 3 0 -Ca enhancer, and the stabilization of IgH-Myc breakpoint regions by microdeletions in S regions residing in the junction flanks.
This study provides evidence that aberrant CSR may play an additional role in the generation of T(12;15) translocations by virtue of transposing IgH fragments containing the intronic heavy-chain enhancer, Em, and short stretches of Sm (truncated switch m regions) into the Myc locus. The Em/Sm transposons may sensitize Myc to perform secondary transchromosomal recombination with S acceptor regions on Chr 12. This results in a T(12;15) translocation that sometimes exhibits special molecular features not present in de novo translocations not preceded by Em/Sm transposition.
Results

Em/Sm transpositions to Myc in BALB/c.IL-6 lymph node cells
Insertions of Em/Sm fragments into the Myc locus have been described previously in three transplanted mouse PCTs (ABPC 17 (Corcoran et al., 1985) , ABPC 45 (Fahrlander et al., 1985) , DCPC 21 (Ohno et al., 1991) ),
but not yet reported in lymphoid tissues of mice with incipient PCTs or tumor-free mice. To determine whether Em/Sm insertions also occurred in such mice, hyperplastic lymph nodes from BALB/c.IL-6 mice were examined. IL-6 transgenic BALB/c mice lend themselves for this examination because they harbor in their lymphoid tissues cell clones with T(12;15) translocations that often utilize the upstream region of Cm for the genetic exchange with Myc (Kovalchuk et al., 2000a) . In addition, these cell clones progress spontaneously and with a high incidence to transplantable PCT tumors (Kovalchuk et al., 2002) . To uncover Em/Sm insertions in Myc, a modification of a PCR protocol for the detection of T(12;15) translocations (Kovalchuk et al., 2000b ) was used to screen a region of Myc that spanned the near 5 0 flank and the beginning of exon 2, thus including Myc's exon 1/intron 1 boundary, the hot spot of translocation breakpoints in BALB/c.IL-6 mice (Kovalchuk et al., 2000a (Kovalchuk et al., , 2002 .
The PCR strategy for detecting Em/Sm insertions is illustrated in Figure 1a . PCR primer pairs, m1a/m3a and m3a/m6a, were utilized to amplify the 1-2.5 kb long Myc-IgH junction fragments labeled '1' and '2,' respectively. These fragments were highly similar to the indicator fragments of a balanced T(12;15) exchange, der (12) (mimicked by fragment 1) and der (15) (mimicked by fragment 2). However, unlike most PCR fragments of this sort, fragments 1 and 2 exhibited an apparent overlap (complete DNA sequence match) in their IgH portion (indicated by the small yellow rectangle), which suggested that the tissue contained a cell clone harboring an Em/Sm insertion in Myc, instead of T(12;15). Primer walking using IgH primers that anneal at increasing distance from the junction sites with Myc offer an opportunity to distinguish between translocations and insertions. In case of a T(12;15) translocation, PCR fragments with theoretically unlimited IgH portions can be generated (the practical limit of PCR is 6-10 kb). In contrast, in case of an Em/Sm insertion, the IgH portion is limited by the size of the IgH region inserted into Myc. Specifically, in the present example, primers m2 and m5 yielded products (fragments '3' and '4') whereas primers m1a/b and m4 did not. It was not possible to extend the IgH portion of fragments 1 and 3 beyond the Myc-IgH junction detected in fragments 2 and 4 (vertical line labeled '3 0 junction'), nor was it possible to extend the IgH portion of fragments 2 and 4 beyond the IgH-Myc junction detected in fragment 1 and 3 (vertical line labeled '5 0 junction'). This finding, in conjunction with the observation that fragments 3 and 4 displayed a longer IgH overlap than fragments 1 and 2 (indicated by the large yellow rectangle), further supported the interpretation that the underlying cell clone harbored an Em/Sm insertion in Myc, rather than T(12;15). The insertion was confirmed in a final PCR reaction using Myc primers, m2 and m3a, to generate the tripartite MycIgH-Myc fragment '5'. The insertion-harboring clone must have been abundant because the Em/Sm insertion was readily detectable in genomic DNA from IL-6 mouse lymph node tissue using one round of PCR (Figure 1a , center) and Southern analysis (Figure 1a , right).
Five of 84 (6%) lymph nodes obtained from 12 T(12;15) + BALB/c.IL-6 mice described in a previous study (Kovalchuk et al., 2000a) contained cell clones with Em/Sm insertions in Myc. Schematic diagrams for inserts 1 and 2 are presented in Figure 1 . Inserts 3-5 are illustrated in a supplementary figure on the web (Web Figure 1 ). All the five insertions mapped to the first intron of Myc, ranged from 2 to 4 kb in length, contained in addition to Em and 5 0 -Sm/Sm regions small stretches of Sg2a (insert 2) or Sg3 (insert 3), occurred in opposite transcriptional orientation of Myc (with the exception of insert 2), and resulted invariably in small deletions in Myc: 21 bp (insert 1), 12 bp (insert 2), 9 bp (insert 3), 47 bp (insert 4), and 23 bp (insert 5) (see Web  Table 2 for junction sites). Inserts 1 and 2 differed from inserts 3-5 with respect to apparent abundance and occurrence of secondary rearrangements. While inserts 1 and 2 were detected after one round of PCR (presumably indicating the presence of an expanded cell clone), detection of inserts 3-5 required two rounds of PCR with nested primer pairs (presumably indicating an underlying cell clone of low abundance). Consistent with the PCR result, inserts 1 and 2 (but not inserts 3-5) were readily detected by Southern blotting (Figure 1 ). The cell clones containing inserts 1 and 2 underwent secondary genetic exchange with Sg1, which was not observed in the tissue samples containing inserts 3-5. It is possible that the detection of the Sg1 rearrangements was facilitated by the size of the parental clones, as expanded clones may be more likely than less abundant clones to spin off progenitors with secondary rearrangements.
Considering that (i) the incoming Sg1 sequence on the derivative products of inserts 1 and 2 (labeled 'Derivative' in Figure 1b ) originated most likely from 0 -Sm. The 803-bp fragment that was coamplified, using the same primers, from the normal Myc gene is also labeled. DNA size markers (SM) are given in kb. Panel a (right): Southern hybridizations to an Em probe (left) and a Myc probe (right). The Myc probe revealed the 10-kb KpnI germline fragment of Myc (black arrow) and a rearranged band that was B2 kb longer and cohybridized to the Em probe (i.e. the Myc gene that harbored the 1658-bp Em/ 5 0 -Sm insert previously detected by PCR). The Em probe revealed in addition to the Myc rearrangement three Chr 12-derived bands: a 14-kb IgH germline fragment labeled 'IgH' and two distinct IgH rearrangements labeled 'IgH-R' (putative VDJ recombinations). DNA size markers are indicated in kb. Panel b illustrates the apparent transchromosomal exchange of two Em/Sm transposons with Cg1. S regions are shown as striped rectangles. All rearrangements are aligned at the 3 0 junction in Myc (thin vertical line). The putative T(12;15) translocation is depicted by a black vertical arrow that is labeled 'T(12;15).' Insert 2, an Em/Sm/Sg2a transposon, was detected by Southern blotting, using the same probes used for insert 1. Junctional sequences (numbered blue arrow heads pointing up) are given in Web Table 2 . Molecular schemes of three additional inserts detected by PCR (but not by Southern analysis) are shown in Web Figure 1 the IgH locus at 12F1, (ii) the fine structure of the observed Myc-Cg1 rearrangements was indistinguishable from Myc-Cg1 rearrangements in T(12;15) + PCT tumors, and (iii) IL-6 transgenic mice tend to utilize Sg1 for CSR in normal B cells (Raynal et al., 1989) and T(12;15) in PCT tumor cells (Kovalchuk et al., 2002) , it is likely that the derivative Myc-Cg1 fragments indicated an underlying T(12;15). However, this was not demonstrated in FISH studies (results not shown), presumably because the T(12;15) + cells were too infrequent (requiring two rounds of PCR for detection) to be confirmed by FISH. Attempts to verify the insertion-derived translocations in transplantation studies (results not shown) also remained inconclusive, as the transfer of lymph node cells harboring inserts 1 and 2 into pristane-primed BALB/c mice did not result in the growth of PCT tumors.
Em/Sm inversions in B cells undergoing CSR
Em/Sm inversions within the IgH locus and Em/Sm transpositions to non-IgH loci, such as Myc, may be different outcomes of the same process: the liberation of Em/Sm fragments by two adjacent DNA double-strand breaks in IgH. To examine whether Em/Sm fragments can be excised from chromosomal DNA of IL-6 transgenic B cells and then reintegrated into IgH in inverted orientation, genomic DNA was prepared from splenic LPS blasts undergoing CSR to Cg1 in vitro (Luby et al., 2001) .
The PCR method for the detection of Em/Sm inversions is depicted in Figure 2 . Panel a shows the location and orientation of the primers. Panel b illustrates the four-step protocol to detect the Em/Sm inversion depicted in red in the molecular scheme of IgH. Primer pairs m1a/b and m3a/b were used to amplify the inversion of the 5 0 most portion of Sm (fragment 1) and primer pairs m4 and m6a/b were used to amplify the inversion of Em (fragment 2). Fragments 1 and 2 were then extended with primers m2 and m5, respectively, resulting in fragments 3 and 4. Fragments 1 and 3 and fragments 2 and 4, respectively, contained the same recombination sites, labeled '5 0 junction' and '3 0 junction' (red arrowheads pointing down). In addition, fragments 3 and 4 exhibited a considerable overlap because of DNA sequence identity, which is indicated by the yellow rectangle. These findings demonstrated that all four fragments were part of the same Em/Sm inversion in IgH. Web Figure 2 depicts seven examples of fully characterized Em and/or Sm inversion events detected in IL-6 transgenic B cells. The corresponding junction sites were determined by DNA sequencing and are presented in Web Table 3 .
Numerous additional PCR products indicative of Em/ Sm inversions and Em/Sm deletions were obtained from IL-6 transgenic B cells undergoing CSR in vitro. However, they were not fully sequenced and therefore not included here. Furthermore, inversions of short stretches of IgH are apparently not restricted to the 5 0 -Cm region (Em and Sm), as Sgb2 inversions were also observed in related studies with IL-6 transgenic B cells (results not shown). Together, these findings indicate that Em/Sm inversions, Em/Sm transpositions to Myc, and Em/Sm deletions (important for isotype stabilization (Zhang et al., 1995) ), may be different outcomes of the same DNA recombination process taking place in normal B cells (Dunnick et al., 1993) . Thus far these outcomes have been detected mainly in malignant B cells, presumably because the amplification of malignant clones facilitated the molecular analysis. The IL-6-driven expansion of normal B/plasma cell clones, an intrinsic feature of the BALB/c.IL-6 model, seems to permit the detection of the similar aberrations in normal cells, thus circumventing the requirement for a malignant clone. Junction site according to the numbers in Figure 2; 3 Genes joined at junction site; 4 5 0 flank denote DNA sequences to the left and the right of the junction sites indicated in Figure 2 . A reference to the transcriptional orientation of the recombined genes is not intended; 5 Recombination breakpoint. Microhomologies at the breaksite; that is, nucleotides that could have been derived from either partner of recombination, are indicated. Blunt breakpoints without microhomologies are indicated by a hyphen; 6 3 0 flank denote DNA sequences to the left and the right of the junction sites indicated in Figure 2 . A reference to the transcriptional orientation of the recombined genes is not intended; 7 Access name of GenBank file; 8 GenBank DNA sequence file position of nucleotide at junction site; 9 20-bp sequence flanking the junction site. Discrepancies with GeneBank sequences that may indicate strain polymorphisms or mutations, such as base substitutions and insertions, are indicated in capital letters results in translocation junctions whose fine structure varies in accordance with the orientation of the Em/Sm transposon in Myc. The scheme to the left shows that T(12;15) causes characteristic S sequence inversions at both translocation breakpoints when Em/Sm transposition occurs in the same transcriptional orientation as Myc (5 0 to 3 0 ). The hypothetical exchange of Sm on Chr 15 (blue) and Sa on Chr 12 (green) demonstrates that the Sm portion of the resulting Sm/Sa region is inverted with respect to the orientation of IgH on both products of translocation. Sm inversion at translocation breakpoint junctions thus indicates that the translocation was preceded by S insertion in Myc. Although the insertional junction sites in Myc are retained on both rearranged chromosomes (black arrowheads pointing down), they can easily be mistaken for IgH-Myc translocation breakpoints if the possibility of a preceding Em/Sm insertion is not considered. A well-documented example of this sort is the mouse PCT, TEPC 3610, in which the putative Sm insertion junction on der (15) was erroneously identified (by these authors) as translocation breaksite (Kovalchuk et al., 2001) . A related example is the rat immunocytoma, IR75, which harbors an inversion of Sm at the breaksite of a Myc-activating t(6;7) translocation (Pear et al., 1986) .
The scheme to the right in panel a shows that transpositions are not accompanied by S inversions and thus frequently obscured upon T(12;15) exchange when Em/Sm transposition occurs in the opposite transcriptional orientation of Myc (5 0 to 5 0 ). Hybrid S regions, such as the depicted Sm/Sa region, are indistinguishable from composite S regions that would be generated by the exchange of Myc with a unitary Sm region in a preswitch B cell (followed by CSR to Sa at a later developmental stage) or by the exchange of Myc with a chimeric Sm/Sa region in a postswitch B cell. This situation makes it impossible to differentiate the original Em/Sm insertion junctions (black arrowheads pointing down) from translocation breakpoint junctions (thin vertical line).
A molecular fingerprint of a preceding 5 0 to 5 0 transposition is however left behind when special circumstances are met, such as those depicted in panel b. In the example, the Sa portion of a hybrid Sm/Sa (12), would always generate the gene order, Sm-Sg-Sa. Similarly, the gene order, Sg-Sa-Myc, on the reciprocal product of translocation, der (15), is unusual, as a de novo T(12;15) would always produce the order, Sa-Sg-Myc. IgH-Myc junction fragments harboring composite switch regions with unusual gene orders have been repeatedly observed in previous studies (Mu¨ller et al., 1994; Janz et al., 1995; Mu¨ller et al., 1996) , adding credence to the scheme presented in panel b. However, the involvement of S transpositions in the origin of these fragments remains still hypothetical as back switching, a normal transchromosomal CSR event (Esser and Radbruch, 1990) , could also generate the unusual order of switch regions at translocation breaksites. Thus, only the scenario illustrated to the left in panel a generates strong circumstantial evidence that translocation was preceded by transposition.
Since the majority of Em/Sm transpositions found in this study were of the easy-to-obscure 5 0 to 5 0 type (four of five cases), it seems unlikely that these transpositions would be properly identified in molecular studies of T(12;15) + tumors that may evolve from the transposition-carrying clones. It follows that fine structural analyses of T(12;15) + tumors may be of limited value to determine the in vivo frequency of Em/Sm transpositions and, thereby, the biological significance of transposition as precursor of T(12;15). Targeting Myc with a suitably tagged Em/Sm transposon in a mouse knock-in model may be a more promising approach.
Discussion
The uncovering of five cases of Em/Sm transposition to Myc in lymph node cells of IL-6 transgenic BALB/c mice raised the question on the overall frequency of transposition events in vivo. The apparent absence of transposition-bearing cell clones in most lymphoid tissues (79 of 84, 94%) indicated that transpositions are infrequent events. Two additional considerations suggested, however, that the frequency of transpositions was underestimated in this study. First, the employed PCR methods depended upon clonal expansion of transposition-harboring cells and were thus unlikely to detect individual cells with transpositions or microclones of such cells. A second limitation was the presence of T(12;15)-bearing cell clones with Em/Myc rearrangements in their translocation breakpoint junctions. In some lymph node samples, it was impossible to clearly distinguish Em/Myc translocation junctions from Em/Sm transposition junctions in Myc, which left these cases unresolved. Similar problems caused by the coexistence of multiple T(12;15)-carrying cell clones in the same tissue (clonal diversity), further compounded by ongoing alterations of individual translocation breakpoint junctions (clonal diversification), were encountered in a previous study of translocation detection in IL-6 transgenic PCTs (Kovalchuk et al., 2002) . Hence, the in vivo prevalence of Em/Sm transposons remains to be determined.
The molecular mechanism of Em/Sm transposition to Myc and the nature of the cell in which transposition occurs are not known. The most reasonable candidate may be a germinal center B cell, which performs several B-cell-typical DNA recombination processes that effect DNA double-strand breaks in IgH (Papavasiliou and Schatz, 2000) : CSR (Manis et al., 2002) , VDJ hypermutation (Papavasiliou and Schatz, 2002) , and heavy-chain replacement (Chen et al., 1995) . CSR, which has a clearly defined upstream limit in Em with respect to generating strand breakage (Lee et al., 1998; Luby et al., 2001) , may produce breaks in the Sm/5 0 -Sm region but is unlikely to generate breaks in Em or 5 0 of Em. The latter breaks must thus be caused by random breakage (not B-cell specific), heavy-chain replacement, or VDJ hypermutation, which may also be responsible for interrupting Myc (Pasqualucci et al., 2001) . The recent development of AID null mice deficient in CSR and VDJ hypermutation (Muramatsu et al., 2000) offers a unique opportunity to decide among these possibilities.
In two of five cases, Em/Sm transposition to Myc served as apparent precursor of Cg1-Myc rearrangements, which were indistinguishable from Cg1-Myc rearrangements produced by T(12;15) translocations in PCT tumors. Although the underlying biology of the precursor and product relation is not clear, it seems possible that Em/Sm transposition promotes T(12;15)-harboring B-cell clones in two ways. First, the juxtaposition of Em in cis to Myc may confer a growth advantage to the transposition-bearing cell clone, by deregulating Myc expression. Second, the insertion of Sm repeats into Myc may dramatically increase the recombinogenicity of the Myc locus and render the gene susceptible to trans-chromosomal isotype switching with S acceptor regions on Chr 12, resulting in T(12; 15) . This hypothesis is supported by reports on transchromosomal CSR leading to T(12;15) in a mouse PCT (Gerstein et al., 1990) and transchromosomal CSR causing Ig isotype change in a mouse myeloma cell line (Bakkus et al., 2001) .
Myc deregulation conducive to PCT development in mice requires the IgH 3 0 -Ca enhancer (Madisen and Groudine, 1994) if the tumor contains T(12;15), or the interplay of several enhancer elements of the IgL k locus (Hortnagel et al., 1995; Geltinger et al., 1996) or IgL l locus (Axelson et al., 1991) if the tumors harbor T(6;15) or T(15;16). Thus, in contrast to transposition of retroviral LTR enhancers , Em transposition to Myc seems to be insufficient to promote plasmacytomagenesis. This is probably the main reason why all Em transpositions to Myc detected thus far in mouse PCTs were modified by secondary genetic rearrangements. These include (i) T(12;15), as found in PCTs, TEPC 3610 (Kovalchuk et al., 2001) and in this study, (ii) complex multistep recombinations, which often contain features of a T(12;15) exchange (described in ABPC 45 (Fahrlander et al., 1985) , DCPC 21 (Ohno et al., 1989 ), PC 7183 (VanNess et al., 1983 Shapiro and Weigert, 1987) and MPC 11 (Greenberg et al., 1982) ), (iii) and T(6;15), as observed in ABPC 17 (Corcoran et al., 1985) . Thus, the empirical evidence supports the contention that Em transposition to Myc facilitates plasmacytomagenesis indirectly, by sensitizing Myc to secondary exchanges, including T(12;15) translocation.
Findings by other investigators indicate that some human B-cell tumors harbor changes that are highly reminiscent of the transposition and inversion events detected in lymph node cells of BALB/c.IL-6 mice. Em deletions, which were first observed in mouse PCTs (Aguilera et al., 1985) , have recently been found in human MALT lymphomas (Nardini et al., 2000) . Aberrant rearrangements of Sm are remarkably prevalent in human chronic B-cell leukemia (Laffan and Luzzatto, 1992; Crossen and Morrison, 1998 ) but seem to occur also in human multiple myeloma (Proffitt et al., 1999; Pratt et al., 2001) . IgH transposition into oncogenes, such as BCL6 (Chaganti et al., 1998) , or oncogene transposition (e.g. BCL2) into IgH (Vaandrager et al., 2000) have been observed in human diffuse large cell B-cell lymphoma and follicular B-cell lymphoma, respectively. The clearest evidence that IgH enhancer transposition may be directly involved in malignant B-cell development was provided by Kuehl and associates, who demonstrated that the reintegration of the 3-Ca enhancer resulted in overexpression of Cyclin D1 in a human multiple myeloma cell line (Gabrea et al., 1999) . These considerations lead us to conclude that Em/ Sm transposition to Myc in IL-6 transgenic mouse B cells constitutes a mechanism of 'oncogene sensitization' that may also be important for human B-cell tumors, but is much more difficult to discern in human tumors than in the mouse model system.
Materials and methods
Mice and tissue samples
BALB/c.IL-6 congenic mice were derived from H2-L d -IL-6 transgenic C57BL/6 mice (Suematsu et al., 1992) by introgressive backcrossing of the IL-6 transgene onto strain BALB/ c. The mice were bred and maintained in our conventional facility on the NIH campus. A total of 12-10-month-old mice from backcross generations N 12-15 exhibiting generalized lymph node enlargement caused by IL-6 disease were euthanized according to NIH guidelines to harvest a total of 84 lymphoid tissues: peripheral lymph nodes (inguinal, brachial, axillary, cervical), central lymph nodes (mesenteric, abdominal, pararenal, perithymic), Peyer's patches, and spleen. A previous study demonstrated that 15 of the 84 tissues contained T(12;15) + cell clones with 5 0 -Cm/Myc recombinations in their translocation breakpoint regions (Kovalchuk et al., 2000a) . The same 84 lymphoid tissues were reanalysed in this study to detect cell clones that harbored IgH transpositions to Myc. Spleens were obtained from 6-monthold BALB/c.IL-6 mice from a later backcross generation (N 19 ) to detect Em/Sm inversions in IgH in B cells undergoing CSR in vitro.
PCR analysis
Direct DNA PCR assays were employed to detect Em/Sm transpositions to Myc, Cg1-Myc junctions derived from these transpositions, and Em/Sm inversions in IgH. Em/Sm transpositions were detected according to the protocol illustrated in Figure 1a . Cg1-Myc junction fragments derived from Em/Sm transpositions were detected as previously described (Kovalchuk et al., 2000b) . Em/Sm inversions were detected according to the scheme in Figure 2b . For all three assays, genomic DNA was prepared using a standard phenol/chloroform extraction protocol including digestion with proteinase K (100 mg/ml, Boehringer-Mannheim, Indianapolis, IN, USA) and RNAse A (40 mg/ml, Sigma, St Louis, MO, USA). A measure of 500-ng aliquots of genomic DNA were employed in long-template and high-fidelity PCR reactions using kits from BoehringerMannheim (Indianapolis, IN, USA) . Hot-start amplifications with one PCR primer pair were performed with the following cycling conditions: initial denaturation at 961C for 5 min with the reaction subsequently being held at 801C for the addition of polymerase mix (1.75 U/50 ml reaction). This was followed by 25 cycles of template denaturation at 951C for 30 s, primer annealing at 621C for 30 s, and primer extension at 681C for 1-7 min in the first cycle with a progressive prolongation of the extension time by 20 s for each of the subsequent cycles. Final extension times thus amounted from 9 to 14.5 min. In case of two-round amplifications, 1-5 ml of the reaction mixture from round one was used in the second round of PCR with nested or semi-nested primer pairs for 25 cycles of reamplification. The concentration of dNTPs (200 mm) and Mg 2+ (1.5-1.75 mm final) was the same in both rounds of PCR. PCR primers were chosen with help of the Oligo 4.1 software (National Biosciences, Plymouth, MN, USA; Web Table 1 ). Primers with the suffix 'a' were used in one-round PCR amplifications and primers with the suffix 'b' were used as nested primers in the second round of two-round PCR amplifications. To exclude artefactual PCR results, all PCR products were amplified at least twice.
DNA sequencing
PCR fragments were gel purified with the QIAquick gel extraction kit (Qiagen, Valencia, CA, USA) and sequenced using the Femtomole cycle sequencing kit (Promega, Madison, WI, USA). Direct sequencing circumvented common cloning artefacts of S region-containing DNA fragments, such as internal deletions in S regions, which occur even in recombination-deficient Escherichia coli strains. To complete the sequence analysis of PCR products that were too large to be determined in one sequence run from both ends, additional internal sequences were generated using internal sequencing primers. To minimize sequencing errors of junction sites, all junctional sequences were determined at least twice.
Southern analysis
To detect Em/Sm transpositions to Myc by Southern blot hybridization, genomic DNA was digested with KpnI, fractionated by electrophoresis on 0.7% agarose gels, transferred onto a nitrocellulose membrane, and hybridized to a 2.2-kb NheI/SpeI fragment of Myc that included exon 2 ('Myc probe'), or to a 1.5-kb HindIII/EcoRI fragment of IgH that spanned J H 2 and Em ('Em probe'). Probes were labeled with 32 P-dCTP by random priming using a commercial kit.
Abbreviations CSR, class switch recombination; Ig, immunoglobulin; IgH, Ig heavy-chain gene complex; PCT(s), plasmacytoma(s); S, Ig switch regio.
